R Squared Ltd Sells 2,979 Shares of Intuitive Surgical, Inc. $ISRG

R Squared Ltd trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 79.5% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 770 shares of the medical equipment provider’s stock after selling 2,979 shares during the quarter. R Squared Ltd’s holdings in Intuitive Surgical were worth $436,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in ISRG. Draper Asset Management LLC boosted its stake in shares of Intuitive Surgical by 41.9% in the 4th quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock valued at $2,848,000 after purchasing an additional 1,485 shares during the last quarter. SteelPeak Wealth LLC boosted its stake in shares of Intuitive Surgical by 28.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after purchasing an additional 9,364 shares during the last quarter. Atlantic Union Bankshares Corp boosted its stake in shares of Intuitive Surgical by 19.3% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock valued at $10,179,000 after purchasing an additional 3,676 shares during the last quarter. Valley Wealth Managers Inc. boosted its stake in shares of Intuitive Surgical by 52.7% in the 3rd quarter. Valley Wealth Managers Inc. now owns 4,084 shares of the medical equipment provider’s stock valued at $1,826,000 after purchasing an additional 1,409 shares during the last quarter. Finally, AGF Management Ltd. boosted its stake in shares of Intuitive Surgical by 0.6% in the 3rd quarter. AGF Management Ltd. now owns 464,179 shares of the medical equipment provider’s stock valued at $207,595,000 after purchasing an additional 2,575 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 421 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the transaction, the executive vice president owned 409 shares of the company’s stock, valued at $202,438.64. This represents a 50.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Mark Brosius sold 2,362 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16. Following the transaction, the senior vice president directly owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. This trade represents a 39.93% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 5,413 shares of company stock worth $2,681,362. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $466.64 on Wednesday. The business has a 50 day simple moving average of $476.64 and a 200 day simple moving average of $516.83. Intuitive Surgical, Inc. has a 52-week low of $427.84 and a 52-week high of $603.88. The stock has a market cap of $165.27 billion, a price-to-earnings ratio of 56.56, a PEG ratio of 3.79 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period in the prior year, the business earned $1.81 EPS. Intuitive Surgical’s revenue for the quarter was up 23.0% compared to the same quarter last year. On average, analysts predict that Intuitive Surgical, Inc. will post 8.5 EPS for the current year.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Q1 2026 beat and buyback completion — Intuitive reported revenue of $2,770.8M and net income of $821.5M, and completed a multiyear repurchase of 29,440,210 shares for $9.08B, reducing share count and boosting EPS. How Strong Q1 2026 Results and Completed Buyback Will Impact Intuitive Surgical (ISRG) Investors
• Positive Sentiment: Procedure growth and platform adoption highlighted on the call — Management cited a ~17% increase in procedures and broad adoption of da Vinci and Ion platforms, including gains outside urology, which supports durable revenue growth. 5 Revealing Analyst Questions From Intuitive Surgical’s Q1 Earnings Call
• Positive Sentiment: Analyst price-target upside — The consensus of Wall Street analysts implies ~25% upside to current levels, reflecting upward revisions to earnings expectations. This gives technical and fundamental case for more upside if execution continues. Wall Street Analysts See a 25.06% Upside in Intuitive Surgical (ISRG)
• Positive Sentiment: Investor-focused bullish write-ups — Several outlets (including 24/7 Wall St.) view the recent pullback as a buying opportunity, reiterating long-term adoption tailwinds and high price targets. Why Intuitive Surgical Is a Strong Buy as Robotic Surgery Adoption Accelerates
• Positive Sentiment: Sector tailwinds and thematic calls — ISRG is featured in lists of robotics/AI-enabled stocks, and market research projects the U.S. medical robotics market growing strongly through 2035, supporting long-term demand. 5 Stocks to Buy With Extensive Robotics Applications for 2026 Medical Robotics Market Size to Grow
• Neutral Sentiment: Sector/company attention — ISRG is a trending stock on some platforms, which can increase intraday volatility but isn’t a direct fundamental change. Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
• Neutral Sentiment: Peer/sector results and startup activity — Zimmer Biomet’s earnings and early-stage robotics funding (SquareMind) provide sector context but don’t materially change Intuitive’s own fundamentals. ZBH Q1 Earnings & Revenues Top Estimates SquareMind Raises $18 Million to Redefine Skin Exams

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on ISRG. Argus reduced their target price on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. JPMorgan Chase & Co. reduced their target price on shares of Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Leerink Partners lowered their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. Mizuho set a $525.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research note on Monday, April 13th. Finally, Raymond James Financial lowered their price target on Intuitive Surgical from $615.00 to $577.00 and set an “outperform” rating for the company in a research note on Wednesday, April 22nd. Eighteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $581.91.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.